GenEdit
- Biotech or pharma, therapeutic R&D
GenEdit is a platform company developing next generation autoimmune, immuno-oncology, and nervous system therapies through targeted delivery of genetic medicines using its NanoGalaxy platform which utilizes its proprietary hydrophilic nanoparticles to deliver mRNA, siRNA, and other payloads to specific organs and cells of interest.